Metoprolol Succinate NDC 68788-8448

Product information

Brand name (proprietary)

Metoprolol Succinate

Generic name (nonproprietary)

metoprolol succinate

Active ingredients

Metoprolol tartrate — 100 mg/1

Dosage form

Tablet, Extended release

Route

Oral

Labeler

Preferred Pharmaceuticals Inc

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 207206

Marketing start

May 15, 2023

Listing expires

Dec 31, 2027

Other FDA classes

Adrenergic beta-Antagonists (Mechanism)

Identifiers

Product ID 68788-8448_397f7c35-3907-4a9a-921f-598fe724163bSPL ID 397f7c35-3907-4a9a-921f-598fe724163bSPL set ID 0ded3105-b962-4748-bf5b-fca7a4557562RxCUI 866412UNII W5S57Y3A5L

Pharmacologic class

beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788844801 followed by a unit qualifier and the quantity Copy

Package 68788-8448-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 207206

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.